Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Words of wisdom: Re: Do adenocarcinomas of the prostate with Gleason Score (GS) ≤ 6 have the potential to metastasize to lymph nodes?

Richards K, Eggener S.

Eur Urol. 2013 May;63(5):960. doi: 10.1016/j.eururo.2013.02.014. No abstract available.

PMID:
23541252
2.

Words of wisdom. Re: Do adenocarcinomas of the prostate with Gleason Score (GS) ≤ 6 have the potential to metastasize to lymph nodes?

Thalmann GN.

Eur Urol. 2013 Dec;64(6):1013. doi: 10.1016/j.eururo.2013.09.029. No abstract available.

PMID:
24209448
3.

Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer.

Roach M 3rd, Marquez C, Yuo HS, Narayan P, Coleman L, Nseyo UO, Navvab Z, Carroll PR.

Int J Radiat Oncol Biol Phys. 1994 Jan 1;28(1):33-7. Review.

PMID:
7505775
4.

Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.

Turker P, Bas E, Bozkurt S, Günlüsoy B, Sezgin A, Postacı H, Turkeri L.

Urol Oncol. 2013 Jan;31(1):93-8. doi: 10.1016/j.urolonc.2010.10.009.

PMID:
21316989
5.

Gleason score 7 adenocarcinoma of the prostate with lymph node metastases: analysis of 184 radical prostatectomy specimens.

Kryvenko ON, Gupta NS, Virani N, Schultz D, Gomez J, Amin A, Lane Z, Epstein JI.

Arch Pathol Lab Med. 2013 May;137(5):610-7. doi: 10.5858/arpa.2012-0128-OA.

PMID:
23627451
6.

Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.

Sinha AA, Quast BJ, Wilson MJ, Fernandes ET, Reddy PK, Ewing SL, Gleason DF.

Cancer. 2002 Jun 15;94(12):3141-9.

7.

Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.

Arenas LF, Füllhase C, Boemans P, Fichtner J.

Aktuelle Urol. 2010 Jan;41 Suppl 1:S10-4. doi: 10.1055/s-0029-1224663.

PMID:
20094944
8.

Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy.

Khoddami SM, Shariat SF, Lotan Y, Saboorian H, McConnell JD, Sagalowsky AI, Roehrborn CG, Koeneman KS.

BJU Int. 2004 Jul;94(1):42-6.

9.

Biochemical recurrence in Gleason score 7 prostate cancer in korean men: significance of the primary Gleason grade.

Ro YK, Lee S, Jeong CW, Hong SK, Byun SS, Lee SE.

Korean J Urol. 2012 Dec;53(12):826-9. doi: 10.4111/kju.2012.53.12.826.

10.

Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score.

Schiavina R, Borghesi M, Brunocilla E, Manferrari F, Fiorentino M, Vagnoni V, Baccos A, Pultrone CV, Rocca GC, Rizzi S, Martorana G.

BJU Int. 2013 Jun;111(8):1237-44. doi: 10.1111/j.1464-410X.2012.11602.x.

11.

Patient risk stratification using Gleason score concordance and upgrading among men with prostate biopsy Gleason score 6 or 7.

Serkin FB, Soderdahl DW, Cullen J, Chen Y, Hernandez J.

Urol Oncol. 2010 May-Jun;28(3):302-7. doi: 10.1016/j.urolonc.2008.09.030.

PMID:
19117774
12.

Impact of Gleason pattern up gradation after radical prostatectomy for carcinoma prostate patients with low biopsy score (≤ 6).

Kulkarni JN, Valsangkar RS, Jadhav YR, Singh DP.

J Cancer Res Ther. 2011 Oct-Dec;7(4):459-62. doi: 10.4103/0973-1482.92021.

13.

Histopathological prostate cancer characteristics at radical prostatectomy after population based screening.

Hoedemaeker RF, Rietbergen JB, Kranse R, Schröder FH, van der Kwast TH.

J Urol. 2000 Aug;164(2):411-5.

PMID:
10893598
15.

How much does Gleason grade of follow-up biopsy differ from that of initial biopsy in untreated, Gleason score 4-7, clinically localized prostate cancer?

Choo R, Danjoux C, Morton G, Szumacher E, Sugar L, Gardner S, Kim M, Choo CM, Klotz L.

Prostate. 2007 Nov 1;67(15):1614-20.

PMID:
17823923
16.

Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.

Lughezzani G, Gallina A, Larcher A, Briganti A, Capitanio U, Suardi N, Lista G, Abrate A, Sangalli MN, Buffi N, Cestari A, Guazzoni G, Rigatti P, Montorsi F.

BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x.

17.

Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years.

Rajinikanth A, Manoharan M, Soloway CT, Civantos FJ, Soloway MS.

Urology. 2008 Jul;72(1):177-82. doi: 10.1016/j.urology.2007.10.022.

PMID:
18279938
18.

Prostate needle biopsies: interobserver variation and clinical consequences of histopathological re-evaluation.

Berg KD, Toft BG, Røder MA, Brasso K, Vainer B, Iversen P.

APMIS. 2011 Apr;119(4-5):239-46. doi: 10.1111/j.1600-0463.2011.02723.x.

PMID:
21492223
19.
20.

E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens.

De Marzo AM, Knudsen B, Chan-Tack K, Epstein JI.

Urology. 1999 Apr;53(4):707-13.

PMID:
10197845
Items per page

Supplemental Content

Support Center